AEON vs REGN: Which Stock is Better?
Side-by-side comparison of Aeon Biopharma Inc and Regeneron Pharmaceuticals Inc in 2026
AEON
Aeon Biopharma Inc
$1.20
REGN
Regeneron Pharmaceuticals Inc
$733.78
Key Metrics Comparison
| Metric | AEON | REGN | Winner |
|---|---|---|---|
| Market Cap | $10.95M | $77.77B | REGN |
| P/E Ratio | N/A | 17.58 | REGN |
| EPS (TTM) | $N/A | $41.75 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 45.8% | REGN |
Analyze AEON
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AEON or REGN a better investment?
Comparing AEON and REGN: Aeon Biopharma Inc has a market cap of $10.95M while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AEON and REGN?
AEON (Aeon Biopharma Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AEON or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AEON or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for AEON.
Which company is more profitable: AEON or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to 0.0% for AEON.
Which is the larger company: AEON or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $10.95M for AEON.
Should I buy AEON or REGN in 2026?
Both AEON and REGN have investment merit. AEON trades at $1.20 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AEON and REGN stock?
Key differences: Market Cap ($10.95M vs $77.77B), P/E Ratio (N/A vs 17.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 45.8%).